We have located links that may give you full text access.
PER3 VNTR polymorphism in Multiple Sclerosis: A new insight to impact of sleep disturbances in MS.
Multiple Sclerosis and related Disorders 2017 October
BACKGROUND: Multiple Sclerosis (MS) is a degenerative disease of central nervous system caused by an immune response against the myelin. About half of MS patients suffers from sleep disturbances. The circadian clock genes such as PER3 controls circadian rhythm and sleep. Due to the role of PER3 in sleep disturbances and regulation of immune response, it is possible that PER3 dysregulation increase risk of MS disease.
METHODS: Study groups included 160 MS patients and 160 healthy volunteers. PER3 VNTR polymorphism was evaluated by PCR method. The genotypic and allelic distribution analyzed by chi square test.
RESULTS: There was a significant association between genotype PER34/4 , and 4-repeat allele with MS disease (p = 0.014 and p < 0.001 respectively). The association analysis of PER3 VNTR polymorphism with gender status among MS group, and MS onset showed that there was a significant correlation between PER34/4 genotype with female gender and early onset of MS disease (p = 0.033 and p = 0.028 respectively).
CONCLUSION: Our data suggest that, PER34/4 genotype may accelerate the course of disease in MS susceptible individuals.
METHODS: Study groups included 160 MS patients and 160 healthy volunteers. PER3 VNTR polymorphism was evaluated by PCR method. The genotypic and allelic distribution analyzed by chi square test.
RESULTS: There was a significant association between genotype PER34/4 , and 4-repeat allele with MS disease (p = 0.014 and p < 0.001 respectively). The association analysis of PER3 VNTR polymorphism with gender status among MS group, and MS onset showed that there was a significant correlation between PER34/4 genotype with female gender and early onset of MS disease (p = 0.033 and p = 0.028 respectively).
CONCLUSION: Our data suggest that, PER34/4 genotype may accelerate the course of disease in MS susceptible individuals.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app